AVITA Medical appoints Michael Tarnoff to Board; Cary Vance becomes Board Chair

AVITA Medical, Inc.

Dr. Michael Tarnoff appointed as non-executive Director, effective August 6, 2025; most recently Chief Physician Executive and CEO at Tufts Medical Center.
Tarnoff receives $70,000 annual cash retainer, initial equity grant of $210,000 (30% options, 70% RSUs); annual grants subject to shareholder approval.
Cary Vance elected Board Chair, succeeding Lou Panaccio after more than 10 years of service; effective August 7, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.